StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3
Publishing Date
2021 - 07 - 27
3
Sector
Commercial services
1
Health technology
2
Tags
Acquisition
8
Alliances
3
Application
4
Approval
3
Authorized
3
Biocapital
3
Biopharma
4
Bioscience
4
Biotech
4
Biotech-bay
5
Breast cancer
3
Cancer
7
Ceo
3
Charging
4
China
3
Collaboration
4
Commercialization
12
Communication
4
Communications
4
Conference
40
Covid
3
Device
3
Diagnostic
5
Disease
8
Distribution
6
Drug
7
Earnings
5
Energy
11
Ev
6
Events
4
Expansion
4
Fda
5
Financial results
48
Food
5
Genomic
3
Grant
3
Granted
4
Growing
3
Growth
15
Health
6
Imaging
3
Iot
4
License
4
Liver
5
Market
5
Merge
5
N/a
411
Offering
9
Partnership
5
Patent
4
People
4
Potential
4
Research
16
Results
107
Sales
5
Technology
6
Test
9
Treatment
6
Trial
16
Women
4
Entities
Infinity pharmaceuticals, inc.
1
Merck & company, inc.
1
Zhongchao inc.
1
Symbols
INFI
1
MRK
1
ZCMD
1
Exchanges
Nasdaq
2
Nyse
1
Crawled Date
2022 - 06 - 07
2
2022 - 06 - 06
2
2022 - 05 - 05
3
2022 - 05 - 04
3
2022 - 05 - 03
2
2022 - 04 - 28
2
2022 - 04 - 19
2
2022 - 04 - 07
2
2022 - 03 - 31
2
2022 - 03 - 14
3
2022 - 03 - 07
2
2021 - 12 - 15
3
2021 - 12 - 10
14
2021 - 12 - 09
6
2021 - 12 - 08
5
2021 - 12 - 06
2
2021 - 11 - 30
5
2021 - 11 - 29
2
2021 - 11 - 22
3
2021 - 11 - 19
5
2021 - 11 - 18
3
2021 - 11 - 12
2
2021 - 11 - 11
2
2021 - 10 - 28
3
2021 - 10 - 22
2
2021 - 10 - 18
2
2021 - 10 - 15
2
2021 - 10 - 14
2
2021 - 10 - 13
4
2021 - 10 - 11
2
2021 - 10 - 05
3
2021 - 10 - 01
2
2021 - 09 - 16
2
2021 - 09 - 13
2
2021 - 07 - 27
3
2021 - 07 - 14
2
2021 - 06 - 07
3
2021 - 06 - 04
3
2021 - 06 - 03
2
2021 - 06 - 02
2
2021 - 05 - 21
2
2021 - 05 - 19
2
2021 - 05 - 06
2
2021 - 04 - 09
3
2021 - 04 - 08
2
2021 - 03 - 25
2
2021 - 03 - 21
2
2021 - 03 - 01
2
2021 - 01 - 19
2
2020 - 12 - 21
3
2020 - 12 - 17
1
2020 - 12 - 16
1
2020 - 12 - 14
2
2020 - 12 - 11
2
2020 - 12 - 10
3
2020 - 12 - 09
9
2020 - 12 - 08
1
2020 - 12 - 07
1
2020 - 12 - 03
2
2020 - 12 - 01
1
Crawled Time
12:00
1
13:00
1
22:00
1
Source
www.biospace.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Breast cancer
crawled date :
2021 - 07 - 27
save search
Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)
Published:
2021-07-27
(Crawled : 22:00)
- biospace.com/
INFI
|
$0.016
12.5%
1.1M
|
Health Technology
|
-99.28%
|
O:
-25.68%
H:
4.24%
C:
-7.88%
phase 2
cancer
breast cancer
trial
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
Published:
2021-07-27
(Crawled : 13:00)
- prnewswire.com
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
|
-12.12%
|
O:
-1.82%
H:
7.41%
C:
2.78%
treatment
cancer
breast cancer
diagnostic
Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 (CPS ≥10)
Published:
2021-07-27
(Crawled : 12:00)
- biospace.com/
MRK
|
News
|
$125.78
0.44%
0.0%
8.4M
|
Health Technology
|
62.31%
|
O:
-0.09%
H:
1.24%
C:
0.88%
cancer
phase 3
breast cancer
trial
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.